Met Life Investment Management, LLC Clear Point Neuro, Inc. Transaction History
Met Life Investment Management, LLC
- $16.5 Billion
- Q2 2025
A detailed history of Met Life Investment Management, LLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 15,825 shares of CLPT stock, worth $421,419. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,825Holding current value
$421,419% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding CLPT
# of Institutions
105Shares Held
7.85MCall Options Held
116KPut Options Held
46.8K-
Vanguard Group Inc Valley Forge, PA1.48MShares$39.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA625KShares$16.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$9.76 Million0.0% of portfolio
-
State Street Corp Boston, MA333KShares$8.88 Million0.0% of portfolio
-
Morgan Stanley New York, NY332KShares$8.85 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $652M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...